Embecta Corp. provided revenue guidance for the last six months of fiscal year 2022. For the period, the company expects total revenue of approximately $555 million, representing a decrease of approximately 7.0%, as compared to total revenue of $596 million for the last six months of fiscal year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.8 USD | -1.99% |
|
+2.89% | -32.38% |
May. 16 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
May. 09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.38% | 738M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Revenue Guidance for the Last Six Months of Fiscal Year 2022